#TODAY FDA Approves GLP-1 Pill Foundayo: How It Compares to Wegovy
FDA Approves GLP-1 Pill Foundayo: How It Compares to Wegovy
The Food and Drug Administration on Wednesday approved Eli Lilly’s new GLP-1 daily pill called Foundayo. It’s a new option for the millions looking to try weight loss drugs without having to use a needle and it’s set to hit the market next week. It follows the approval of Novo Nordisk’s Wegovy pill in December. NBC’s Anne Thompson reports for TODAY.
» Subscribe to TODAY: https://www.youtube.com/@TODAY
TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY’s Website: https://www.today.com/
Find TODAY on Facebook: https://ift.tt/7xMkXe0
Follow TODAY on Twitter: https://twitter.com/TODAYshow
Follow TODAY on Instagram: https://ift.tt/BIrCNSY
» Stream TODAY All Day: https://ift.tt/qnufxvE
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#fda #glp1 #health
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
コメントを送信